Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. [electronic resource]
Producer: 20110411Description: 369-79 p. digitalISSN:- 1432-0843
- Antineoplastic Combined Chemotherapy Protocols
- Apoptosis -- drug effects
- Biological Transport -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colonic Neoplasms -- drug therapy
- Doxorubicin -- metabolism
- Drug Antagonism
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Drug Synergism
- Humans
- Paclitaxel -- metabolism
- Silymarin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.